There is a troubling imbalance between those who set health research agendas and those who benefit from them — I was part of ...

New study warns of pervasive scientific fraud, revealing organized actors behind industrialized academic misconduct worldwide ...

We expect Zebra to focus on its working capital efficiency and generating free cash flow, though we expect it may take on additional leverage to fund future acquisitions. The firm was highly leveraged ...

“NS&I has a real opportunity to set an example for the wider industry, and could potentially stand to make the process ...

In this video interview, Michael Miller, chief operating officer at Quanterix, discusses how biopharma companies—especially ...